Vericiguat did not reduce the risk of a composite endpoint of time to cardiovascular death or heart failure (HF) hospitalization among patients with HF and reduced ejection fraction (HFrEF) without ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback